Edition:
India

Neovasc Inc (NVCN.TO)

NVCN.TO on Toronto Stock Exchange

4.42CAD
22 Jul 2019
Change (% chg)

-- (--)
Prev Close
$4.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,703
52-wk High
$59.20
52-wk Low
$4.25

Latest Key Developments (Source: Significant Developments)

Neovasc Announces Effective Date Of Share Consolidation
Friday, 28 Jun 2019 

June 28 (Reuters) - Neovasc Inc ::NEOVASC ANNOUNCES EFFECTIVE DATE OF SHARE CONSOLIDATION.NEOVASC - SHARES EXPECTED TO COMMENCE TRADING ON TORONTO STOCK EXCHANGE ON A POST-CONSOLIDATION BASIS ON OR ABOUT OPENING OF TRADING ON JULY 2, 2019.  Full Article

Neovasc Resolves Three Claims For Correction Of Patent Inventorship Made By Edwards Lifesciences CardiAQ LLC
Thursday, 18 Apr 2019 

April 17 (Reuters) - Neovasc Inc ::NEOVASC ANNOUNCES RESOLUTION OF LAST REMAINING ACTIVE LITIGATION.NEOVASC - HAS RESOLVED THREE CLAIMS FOR CORRECTION OF PATENT INVENTORSHIP MADE BY EDWARDS LIFESCIENCES CARDIAQ LLC IN U.S. COURT.  Full Article

Neovasc Announces Pricing Of $5 Mln Public Offering Of Common Shares
Wednesday, 13 Mar 2019 

March 13 (Reuters) - Neovasc Inc ::NEOVASC ANNOUNCES PRICING OF $5 MILLION PUBLIC OFFERING OF COMMON SHARES.SAYS OFFERING OF 11.1 MILLION COMMON SHARES PRICED AT $0.45PER SHARE.  Full Article

Neovasc Announces Proposed Public Offering Of Common Shares
Wednesday, 13 Mar 2019 

March 12 (Reuters) - Neovasc Inc ::NEOVASC ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES.NEOVASC INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR DEVELOPMENT AND COMMERCIALIZATION OF NEOVASC REDUCER, DEVELOPMENT OF TIARA.  Full Article

Neovasc Inc - On Feb 19, 2019, Company Entered Into A Settlement Agreement With MID
Wednesday, 20 Feb 2019 

Feb 20 (Reuters) - Neovasc Inc ::NEOVASC PROVIDES CORPORATE UPDATE.NEOVASC INC - ON FEBRUARY 19, 2019, COMPANY ENTERED INTO A SETTLEMENT AGREEMENT WITH MID.NEOVASC INC - AGREEMENT RESOLVES CERTAIN POTENTIAL CLAIMS AGAINST COMPANY THAT WERE DESCRIBED IN ITS MANAGEMENT'S DISCUSSION AND ANALYSIS FOR Q3 2018.NEOVASC INC - SETTLEMENT AGREEMENT CONTEMPLATES CERTAIN FEES BEING PAID BY NEOVASC TO MID.NEOVASC INC - NEOVASC WILL PAY MID A ROYALTY OF 1.3% ON ANNUAL NET SALES OF TIARA.  Full Article

Neovasc Receives Approval To Proceed With Phase 2 Of Tiara-Ii Study
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - Neovasc Inc ::NEOVASC RECEIVES APPROVAL TO PROCEED WITH PHASE 2 OF TIARA-II STUDY FROM CLINICAL REGULATORS IN GERMANY AND THE UK.NEOVASC - APPROVAL COMES FOLLOWING CLINICAL EVENTS COMMITTEE ADJUDICATION OF ADVERSE EVENTS, DATA AND SAFETY MONITORING BOARD REVIEW OF DATA, OTHER.NEOVASC - APPROVAL WILL ALLOW TIARA-II STUDY TO PROCEED IN THESE GEOGRAPHIES WITH NO RESTRICTIONS.  Full Article

Neovasc Announces Dismissal Of Claim Brought By Edwards Lifesciences
Tuesday, 22 Jan 2019 

Jan 22 (Reuters) - Neovasc Inc ::NEOVASC ANNOUNCES DISMISSAL OF CLAIM BROUGHT BY EDWARDS LIFESCIENCES.  Full Article

Neovasc Inc - QTRLY Loss Per Share $0.70
Thursday, 15 Nov 2018 

Neovasc Inc ::NEOVASC ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.NEOVASC INC - QTRLY LOSS PER SHARE $0.70.  Full Article

Neovasc Provides Initial Comments On Lawsuit
Tuesday, 11 Sep 2018 

Sept 11 (Reuters) - Neovasc Inc ::NEOVASC PROVIDES INITIAL COMMENTS ON LAWSUIT.NEOVASC INC - COMPLAINT HAS NOT YET BEEN SERVED ON COMPANY.NEOVASC INC - MADE AWARE OF A LAWSUIT FILED BY ENDOVALVE INC. AND MICRO INTERVENTIONAL DEVICES, INC.NEOVASC INC - IF PLAINTIFFS DO SERVE COMPLAINT, CO INTENDS TO DEFEND THE LAWSUIT.NEOVASC - FILED LAWSUIT FOR SOME ALLEGATIONS RELATING TO NEOVASC'S TRANSCATHETER MITRAL VALVE TECHNOLOGY, INCLUDING TIARA DEVICE.  Full Article

Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Neovasc Inc ::CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING.  Full Article